Cocaine self-administration in dopamine-transporter knockout mice

The plasma membrane dopamine transporter (DAT) is responsible for clearing dopamine from the synapse. Cocaine blockade of DAT leads to increased extracellular dopamine, an effect widely considered to be the primary cause of the reinforcing and addictive properties of cocaine. In this study we tested whether these properties are limited to the dopaminergic system in mice lacking DAT. In the absence of DAT, these mice exhibit high levels of extracellular dopamine, but paradoxically still self-administer cocaine. Mapping of the sites of cocaine binding and neuronal activation suggests an involvement of serotonergic brain regions in this response. These results demonstrate that the interaction of cocaine with targets other than DAT, possibly the serotonin transporter, can initiate and sustain cocaine self-administration in these mice.

[1]  H. Fibiger,et al.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine , 1977, Pharmacology Biochemistry and Behavior.

[2]  H. Fibiger,et al.  Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens , 1980, Pharmacology Biochemistry and Behavior.

[3]  R. Tessel,et al.  Nisoxetine and amphetamine share discriminative stimulus properties in mice , 1983, Pharmacology Biochemistry and Behavior.

[4]  G. Barr,et al.  Pharmaco-ontogeny of reward: enhancement of self-stimulation by D-amphetamine and cocaine in 3- and 10-day-old rats. , 1986, Brain research.

[5]  M. Kuhar,et al.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.

[6]  R. Wise,et al.  A psychomotor stimulant theory of addiction. , 1987, Psychological review.

[7]  R. Spealman,et al.  Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.

[8]  M W Fischman,et al.  The pharmacology of cocaine related to its abuse. , 1989, Pharmacological reviews.

[9]  R. Spealman,et al.  Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. , 1989, Molecular pharmacology.

[10]  G. Forloni,et al.  Increased tryptophan hydroxylase mRNA in raphe serotonergic neurons spared by 5,7-dihydroxytryptamine. , 1990, Brain research. Molecular brain research.

[11]  M. Carroll,et al.  Fluoxetine reduces intravenous cocaine self-administration in rats , 1990, Pharmacology Biochemistry and Behavior.

[12]  M. Kuhar,et al.  Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. , 1990, Life sciences.

[13]  J. B. Appel,et al.  Involvement of dopamine uptake in the discriminative stimulus effects of cocaine1,2 , 1991, Behavioural pharmacology.

[14]  T. Curran,et al.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. , 1991, Annual review of neuroscience.

[15]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[16]  S. Tejani-butt [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. , 1992, The Journal of pharmacology and experimental therapeutics.

[17]  F I Carroll,et al.  In vivo binding of [125I] RTI‐55 to dopamine transporters: Pharmacology and regional distribution with autoradiography , 1992, Synapse.

[18]  F I Carroll,et al.  High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain , 1992, Synapse.

[19]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[20]  E. J. Nestler Cellular responses to chronic treatment with drugs of abuse. , 1993, Critical reviews in neurobiology.

[21]  A. Konopka,et al.  A Structure-Activity Study with Aryl Acylamidases , 1994, Applied and environmental microbiology.

[22]  M. Fujita,et al.  Distribution of cocaine recognition sites in rat brain: In vitro and ex vivo autoradiography with [125I]RTI-55 , 1994, Journal of Chemical Neuroanatomy.

[23]  G. Baker,et al.  Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food , 1994, Pharmacology Biochemistry and Behavior.

[24]  G. Rudnick,et al.  Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. , 1994, The Journal of biological chemistry.

[25]  D. Mash,et al.  Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization , 1994, Journal of neurochemistry.

[26]  G. Chiara The role of dopamine in drug abuse viewed from the perspective of its role in motivation , 1995 .

[27]  L. Howell,et al.  Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. , 1995, The Journal of pharmacology and experimental therapeutics.

[28]  R. Spealman Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. , 1995, The Journal of pharmacology and experimental therapeutics.

[29]  T. Nishikawa,et al.  Methamphetamine-induced nuclear c-Fos in rat brain regions , 1995, Neurochemistry International.

[30]  Yasuhiro Watanabe,et al.  Phencyclidine-induced expression of c-Fos-like immunoreactivity in mouse brain regions , 1996, Neurochemistry International.

[31]  C. Chiamulera,et al.  The Reinforcing Properties of Nicotine are Associated with a Specific Patterning of c‐fos Expression in the Rat Brain , 1996, The European journal of neuroscience.

[32]  L. Parsons,et al.  Serotonin1B receptor stimulation enhances dopamine-mediated reinforcement , 1996, Psychopharmacology.

[33]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[34]  J. Meyer,et al.  Characterization and localization of [125I]RTI-55-labeled cocaine binding sites in fetal and adult rat brain. , 1996, The Journal of pharmacology and experimental therapeutics.

[35]  G. Aghajanian,et al.  LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. , 1996, The Journal of pharmacology and experimental therapeutics.

[36]  R. Hen,et al.  Intravenous Cocaine Self-Administration in Mice Lacking 5-HT1B Receptors , 1997, Pharmacology Biochemistry and Behavior.

[37]  S. J. Gatley,et al.  Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects , 1997, Nature.

[38]  M. Greenberg,et al.  FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[40]  S. J. Gatley,et al.  Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.

[41]  G. Gopinath,et al.  Role of Medial Preoptic Area Beta Adrenoceptors in the Regulation of Sleep-Wakefulness , 1997, Pharmacology Biochemistry and Behavior.

[42]  S. Walsh,et al.  Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine , 1997, Psychopharmacology.

[43]  R. Hen,et al.  Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor , 1998, Nature.

[44]  R. Wightman,et al.  Profound neuronal plasticity in response to inactivation of the dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.